Arterial Cannula Market Set for Rapid Growth at 6.5% CAGR: MarkNtel Advisors

Market Overview:

MarkNtel Advisors has released a new report that highlights the strong growth trajectory of the Arterial Cannula Market, The Global Arterial Cannula Market is projected to grow at a CAGR of around 6.5% during the forecast period, i.e., 2023-28. Various factors are attributed to the growth of the market like growth in automobile production, growing focus on lightweight & sustainable materials, rising demand for luxury & customized interiors, increasing focus on safety standards, and the adoption of Advanced Driver Assistance Systems (ADAS). The report provides valuable insights into the drivers, trends, and challenges shaping the future of the Arterial Cannula Market. It offers an in-depth look at the key players, geographical performance, and the segments leading the charge in market share.

Industry Outlook & Forecasts:

Forecast Period: 2023-2028
CAGR (2023-2028): 6.5%

Key Perks: “In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecasts for the years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.”

Request for a Free PDF Sample of the Report – https://www.marknteladvisors.com/query/request-sample/arterial-cannula-market.html

Global Arterial Cannula Market Segmentation Breakdown:

The Arterial Cannula Market explores the industry by emphasizing the growth parameters and categorizes including geographical segmentation, to offer a comprehensive understanding of the market dynamic. The further bifurcations are as follows:

By Product
- Cardiac Cannulas
- Nasal Cannulas
- Vascular Cannulas
- Dermatology Cannulas
- Arthroscopy Cannulas
- Arthroscopy Cannulas
By Type
- Neonatal Cannulas
- Straight Cannulas
- Winged Cannula
- Wing with Port Cannula
- Others
By Size
- 14G
- 16G
- 18G
- 20G
- 22G
- 24G
- 26G
By Material
- Plastic (PVC) Cannulas
- Silicone Cannulas
- Metal Cannulas (Stainless Steel)
By Application
- Cardiovascular Surgery
- Oxygen Therapy
- General Surgery
- Cosmetic/Plastic Surgery
- Orthopedic Surgery
- Others

Among all, the Cardiovascular Surgical applications of the cannula are anticipated to register the most remarkable growth in the forecast years owing to the high prevalence of cardiac issues globally.

By End User
- Hospitals
- Ambulatory Surgery Centers (ASCs)
- Others

Among the three, Hospitals dominated the industry with the highest market share during the historical period and are expected to prevail in the same trend by garnering the largest market share in the forecast period.

Geographical Growth Insights:

By Region

North America
South America
Europe
The Middle East & Africa
Asia-Pacific

Globally, North America is anticipated to garner the highest market share in the forecasting.

MarkNtel Advisors Highlights Key Market Drivers for Arterial Cannula Market:

Prevalence of Cardiovascular and Cardiopulmonary Illnesses Resulting in Immediate Need for By-Pass Surgeries

According to the study, The Global Burden of Cardiovascular Diseases and Risk, published by JACC, Journal of the American College of Cardiology in December 2022, Cardiovascular diseases (CVDs) have collectively remained the leading causes of death globally, substantially contributing to the loss of health and additional costs on the health system. The more frequent instances of kidney dysfunction, dietary risks, tobacco smoking, secondhand tobacco smoke, high systolic blood pressure, high LDL-C, high body mass index (BMI), high fasting plasma glucose, high alcohol use, and low physical activity as the possible risk factors are anticipated to raise the chances of such diseases.

Given the criticality of such conditions and the immediate urge to minimize them, invasive and efficacious surgical techniques are surfacing, giving rise to innovative medical devices, including arterial cannulae, by numerous manufacturers. For instance,

Medtronic plc, an American medical device company, has come up with product variations to facilitate a variety of surgical techniques and to accommodate varying patient anatomies. In fact, citing the need for distinct devices for pediatrics and adults, the company offers arterial cannulae sizes from 6 Fr to 24 Fr in various tip configurations, lengths, and connector sizes.

Thus, rising cardiovascular conditions and pulmonary illnesses has increased the number of bypass surgeries and other similar procedures, particularly among the geriatric population, significantly elevating the demand for cannulae market.

A Comprehensive Analysis of Leading Companies in Global Arterial Cannula Market

Boston Scientific Corporation
CONMED Corporation
Edwards Lifesciences
LivaNova Plc
Medtronic Plc
Smith & Nephew PLC
Smiths Medical Inc.
Teleflex Incorporated
Terumo Corporation
others

Explore More About This Research Report @ https://www.marknteladvisors.com/research-library/arterial-cannula-market.html

What are the Growth Opportunity driving the Global Arterial Cannula Market?

Scaling Up of Cardiac Surgical Capacity Across the African Continent

The urgent need to address the lack of access to cardiac surgery in African countries presents a significant opportunity for manufacturers of the arterial cannula market. While degenerative cardiovascular diseases are on the rise, structural conditions such as congenital heart disease (CHD) and rheumatic heart disease (RHD) still account for a higher morbidity and mortality rate in Africa than in the rest of the world. As African leaders endorse resolutions to end RHD and scale-up cardiac surgical capacity, the demand for surgical equipment and supplies such as arterial cannulas is expected to increase. Governments in countries such as Namibia, Zambia, and Uganda have already taken steps to improve access to tertiary care, but more needs to be done to meet the current demand for cardiac surgical services in Africa.

Global Arterial Cannula Industry Recent Developments

In April 2023, Boston Scientific Corporationannounced its intention to acquire Shockwave Medical, a company specializing in interventional cardiovascular procedures. This acquisition is part of Boston Scientific’s strategy to expand its range of cardiovascular devices, as Shockwave Medical is a leading medical device manufacturer, based in California.

“Report Delivery Format: Market research reports from MarkNtel Advisors are available in PDF, Excel, and PowerPoint formats. Once payment is successfully processed, the report will be delivered to your email address within 24 hours”

Note: If you need additional information not included in the report, we can customize it to suit your requirements.

Contact Our Analysts for Brochure Requests, Customization, or Any Pre-Purchase Inquiries: https://www.marknteladvisors.com/query/request-customization/arterial-cannula-market.html

About Us –

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

More Research Studies:

S. Anemia Treatment Market size was valued at around USD 1.07 billion in 2024and is projected to reach USD 1.98 billion by 2030 with 10.14% CAGR
Saudi Arabia Event Management Market size was valued at around USD 2.04 billion in 2024and is projected to reach USD 4.26 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 8.24%.
Water Pumps for Food & Beverage Industry size was valued at around USD 3.61 billion in 2024and is projected to reach USD 4.56 billion by 2030 with a CAGR of around 4.7%.